Hims & Hers Health, Inc. HIMS announced that eligible customers can now access six months of prescription-only Wegovy at a ...

We recently published a list of 10 Stocks Got Wiped Out. Are You Holding Any? In this article, we are going to take a look at ...

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth ...

Hims & Hers Health continues to fire on all cylinders as a business. Click here to read why HIMS stock is a Buy.

We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at ...

Online health and wellness company Hims & Hers raised $1 billion through convertible senior notes to grow its international ...

Hims & Hers beat first-quarter profit and revenue forecasts as sales more than doubled. However, the health and wellness platform missed analysts' estimates for current-quarter sales on the impact of ...

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the ...

Health and wellness company, which sold alternatives to weight-loss drugs like Wegovy, is now collaborating with Wegovy-maker Novo Nordisk.

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced its intention to offer, subject to market and other conditions ...

Hims & Hers Health announces plans to offer $450 million worth of convertible senior notes due 2030 in a private offering. Hims & Hers Health intends to use the proceeds to accelerate global ...